TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

Patient-Centric Health Care 

A healthcare professional discussing a matter with a patient.

From diagnoses to treatment for both primary and specialty care, the patient and provider experience is undergoing a dramatic shift. Innovations and policies are repaving the patient journey. 2024 will see further advancements that embed new practices and paradigms. 

What we’re watching 

Beyond pills to durable, lasting treatment benefits 

  • Synthetic biology technologies
  • Disease diagnosis shifting from clunky scans to blood-based assays
  • Gene and cell therapies at commercial scale
  • FDA accelerated approval pathway
  • Liquid biopsy
  • Continued shifts in sites of care
  • Drug pricing 
Themes 2024 Handbook

Browse Cowen’s Themes 2024 Handbook.

Download Handbook

These new treatments are achieving commercial success, with multiple classes of newer modalities surpassing >$1 billion in annual sales per product.